Omnaris and Bactrim ds drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnaris (ciclesonide) and Bactrim ds (sulfamethoxazole; trimethoprim). Common drug interactions include intestinal perforation among females and blood testosterone increased among males.

The phase IV clinical study analyzes what interactions people have when they take Omnaris and Bactrim ds. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

What is Bactrim ds?

Bactrim ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 17,027 Bactrim ds users. Check the latest studies of Bactrim ds.



On Jul, 21, 2026

11 people who take Omnaris and Bactrim ds together, and have interactions are studied.

Omnaris and Bactrim ds drug interactions.

What are the common drug interactions of Omnaris and Bactrim Ds, by gender? *:

female:

  1. Intestinal perforation (complete penetration of the wall of the intestine)
  2. Post procedural infection
  3. Weight decreased
  4. Constipation
  5. Megacolon (a very dilated colon)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Sinus headache (headache caused by sinus infections)
  9. Abdominal pain upper
  10. Anxiety

male:

  1. Blood testosterone increased
  2. Body height decreased
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cough
  6. Drug ineffective
  7. Influenza
  8. Injection site haemorrhage (bleeding from injection site)
  9. Labyrinthitis (inflammation of the labyrinth or inner ear)
  10. Pneumonia

What are the common drug interactions of Omnaris and Bactrim Ds, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cough
  2. Throat tightness
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

20-29:

n/a

30-39:

  1. Abdominal pain upper
  2. Blood pressure increased
  3. Body temperature decreased
  4. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  5. Cystic fibrosis (disease of the secretary glands)
  6. Decreased appetite
  7. Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
  8. Dizziness
  9. Forced expiratory volume decreased (decreased lung expired air volume)
  10. Haematocrit decreased

40-49:

n/a

50-59:

  1. Constipation
  2. Intestinal perforation (complete penetration of the wall of the intestine)
  3. Post procedural infection
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Weight decreased
  7. Body height decreased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Incision site infection (infection at incision site)

60+:

  1. Anxiety
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Dyskinesia (abnormality or impairment of voluntary movement)
  4. Dyspepsia (indigestion)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Emotional disorder
  7. Erythema (redness of the skin)
  8. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  9. Fall
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 36.36%
  2. Hypersensitivity: 3 people, 27.27%
  3. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 18.18%
  4. Cystic Fibrosis (disease of the secretary glands): 2 people, 18.18%
  5. Stress And Anxiety: 1 person, 9.09%
  6. Sleep Disorder: 1 person, 9.09%
  7. Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
  8. Immunodeficiency: 1 person, 9.09%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
  10. High Blood Cholesterol: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Omnaris and Bactrim ds?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnaris and Bactrim ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactrim ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnaris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim ds and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide and sulfamethoxazole; trimethoprim (the active ingredients of Omnaris and Bactrim ds, respectively), and Omnaris and Bactrim ds (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: